36
Program Project IV: The Biology of Chronic Disease Emergence

Program Project IV: The Biology of Chronic Disease … Biology of Chronic Disease Emergence ... CKD, ESRD –PAD, ... • CVD & other chronic disease risk factors had not been

  • Upload
    letram

  • View
    215

  • Download
    2

Embed Size (px)

Citation preview

Program Project IV:

The Biology of Chronic

Disease Emergence

• Add Health Program Project IV:

The Biology of Chronic Disease Emergence

– context for project inception

– motivation for its development

– knowledge gaps

– introduction to the study intent on filling them

– aims

– cohort surveillance initiative

– preliminary findings

– summary

Overview

• As of 2013, cardiovascular disease (CVD) mortality in

the U.S. had been slowly declining

Circulation 2016;133:e38-e360.

Context

Year

CHD

Stroke

Other CVD

Total CVD

Dea

ths

/ 1

00

,000

U.S. Age-Standardized CVD Death Rates, 2000-2013

Source: CDC, NCHS.

Circulation 2016;133:e38-e360.

• However, at that time in the U.S., CVD events were still

– occurring every 34-40 seconds

– accounting for ~ 610-660k new cases / year

– costing us ~ $317 billion / year

• So the national burden of CVD remained quite high…

Context

Age (years)

% o

f P

op

ula

tio

n

CVD Prevalence by Age & Sex, 2009-2012

From NHANES. Source: NCHS & NHLBI.

Dea

ths

in

Th

ou

sa

nd

s

Can

ce

r

Ac

cid

en

ts

CL

RD

DM

AD

Can

ce

r

Ac

cid

en

ts

CL

RD

DM

AD

CV

D

CV

D

Cause

Major Causes of Death by Sex, 2013

Source: NCHS & NHLBI.

Source: NCHS.

Dea

ths

in

Th

ou

sa

nd

s

Age (years)

Top Two Causes of Death by Age, 2013

Circulation 2016;133:e38-e360.

Motivation • Although ~ 70% of CVD can be averted or delayed via

prevention, screening & intervention

– CVD risk reduction in U.S. adults is challenging

• 69% overweight/obese

• 33% hypertensive

• 17% currently smoking

• 13% hypercholesterolemic

• 12% diabetic

– temporal evolution of CVD burden was anticipated

• Although young adults can be mischaracterized as

unburdened by CVD & other chronic diseases

– the challenge of CVD risk reduction isn’t peculiar to

older U.S. adults

– Add Health Wave IV illustrated this…

Motivation

Demogr Res 2015;32:1081–1098.

0

5

10

15

20

25

30

75 85 95 105 115 125 135 >135

%

Waist Circumference (cm)

Add Health Wave IV (2008) NHANES (2007-2008)

0

5

10

15

20

25

30

35

40

20 25 30 35 40 45 50 55 >55

%

Body Mass Index (kg/m2)

Add Health Wave IV (2008)

NHANES (2007-2008)

Anthropometric Risk Factors

0

.01

.0

2

.03

.0

4

Density

50 100 150 200 250

Add Health Wave IV (2008)

NHANES (2007-2008)

Systolic Blood Pressure (mm Hg)

0

.01

.0

2

.03

.0

4

Density

0 50 100 150

Diastolic Blood Pressure (mm Hg)

Add Health Wave IV (2008)

NHANES (2007-2008)

Epidemiol 2011;22(4):532-541 & 544-545.

Cardiovascular Risk Factors

0

.01

.0

2

.03

.0

4

Density

50 100 150 200 250

Glucose (mg/dl)

Add Health Wave IV (2008)

NHANES (2007-2008)

0

.5

1

1.5

D

ensity

4 6 8 10 HbA1c (%)

Add Health Wave IV (2008)

NHANES (2007-2008)

Ann Epidemiol 2014;24(12):903–909.

Metabolic Risk Factors

• These & other factors ↑ risk of subclinical atherosclerosis

or hemorrhage of the arteries supplying e.g.

– brain

– heart

– abdomen

– kidneys

– lower extremities

• The risk often culminates in later life as overt CVD with

obvious implications for public health

– carotid artery disease, TIA, stroke

– CHD, MI, HF

– AAA, dissection, ischemic bowel

– renal artery stenosis, CKD, ESRD

– PAD, critical limb ischemia

Motivation

• Generally, to study emergence of CVD & other chronic

diseases in U.S. adults at risk

• Specifically, to study emergence of CVD & other chronic

diseases in the Add Health cohort through Wave V,

despite its current focus on younger adults

Motivation

• CVD & other chronic disease risk factors had not been

thoroughly examined in a contemporary or nationally

representative study capable of documenting changes in

& manifestations of those risks from adolescence

through 4th decade of life, after which virtually no one

has ideal CV health

• Their examination awaited greater availability, diversity &

generalizability of longitudinal data capable of supporting

epidemiologic inferences about chronic disease risk to

the larger population of young adults

Knowledge Gaps

• Enter

Add Health Program Project IV:

The Biology of Chronic Disease Emergence

• http://www.cpc.unc.edu/projects/addhealth

• https://projectreporter.nih.gov/ (subproject ID: 5096)

Introduction

• (1) Design protocols for collecting bio data / specimens

• (2) Monitor & control field / lab operations so as to

ensure high quality bio data & specimens

• (3) Estimate prevalence / incidence of societally

burdensome chronic diseases & disparities in their

distributions

• (4) Serve as the bio data resource to the program & the

entire scientific community

• (5) Implement a scalable surveillance system for chronic

disease events

Aims

• (1) Design protocols for collecting bio data / specimens

• (2) Monitor & control field / lab operations so as to

ensure high quality bio data & specimens

• (3) Estimate prevalence / incidence of societally

burdensome chronic diseases & disparities in their

distributions

• (4) Serve as the bio data resource to the program & the

entire scientific community

• (5) Implement a scalable surveillance system for chronic

disease events

Aims

• Implement a scalable surveillance system for chronic

disease events

– ascertainment

– review

– adjudication

– classification

• Begin w/ participant deaths due to e.g.

– accidents

– CVD

– cancer

• Thereby position the study for

– ongoing surveillance of mortality

– potential expansion to morbidity

Surveillance

• How do you do that?

– assemble experienced team

Surveillance

Surveillance Team

CSI: Add Health

Surveillance Team

CSI: Add Health

Eric

Whitsel

Laura

Loehr

Bob

Hummer Elyssa

Trani Carol

Murphy

Surveillance Team

• How do you do that?

– assemble experienced team

– develop standardized protocol

Surveillance

Surveillance Protocol

• How do you do that?

– assemble experienced team

– develop standardized protocol

• NDI matching

• CPC scoring

• MOC investigation

• MD review, classification & adjudication

Surveillance

• NDI matching

Determine if Add Health & NDI agree re ≥ 1 of:

– SSN

– month & ±1 year of birth, 1st & last name

– month & ± 1 year of birth, 1st & mid initial, last name

– month & day of birth, 1st & last name

– month & day of birth, 1st & mid initials, last name

Surveillance

• CPC scoring*

Assign points based on match of: – 1st name or initial (0;1) – SSN (0-9)

– middle initial (0;1) – birth day (0;2)

– last name (0;2) – birth month (0;2)

– sex (0;1) – birth year (0;2)

– state of residence (0;1) Sum & group scores, as follows:

Total Group

0-11 non-match

12-19 potential match, investigate

20-21 match

Surveillance

*Based on Atherosclerosis Risk in Communities (ARIC) algorithm.

• MOC investigation

Assemble, abstract & enter into DES – cohort history (automatic)

– obituary

– death certificate

– health provider Q

– ME/coroner report

– next-of-kin interview

– hospital records

• MD review, classification

& adjudication

Surveillance

Preliminary Findings

Case Status Wave 3 Wave 4 Wave 5 Total

Deceased or Unlocatable 96 131 43 270

Matched (1:1) 80 (83%) 115 (88%) 40 (93%) 235 (87%)

Preliminary Findings (n=235)

≥ 10

1-9

0

Decedents

Preliminary Findings (n=235)

2 0

5

13

8

14

12

23

12

16

27

19

15

8 7

11 11 11

7

3

5 4

1 1 0

5

10

15

20

25

30

14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37

N

Age (years)

Characteristic n (%) or mean (range)

Male 160 (68%)

Age 24.3 (14-37)

Preliminary Findings (n=235) • Per NDI, underlying cause of death

– external (73%)

– cancer (6%)

– cardiovascular (5%)

– respiratory (5%)

– infectious / parasitic (2%)

– endocrine / nutritional / metabolic (2%)

– digestive (1%)

– other (7%)

Preliminary Findings

Summary • Add Health Program Project IV:

The Biology of Chronic Disease Emergence

• Scalable surveillance system for chronic disease events

• Our hope is that the data it generates will help

– support your research

– generate actionable, timely knowledge for public

health professionals at the local, state, regional &

national levels

– assess the latest DHHS & AHA prevention efforts

• by 2016, to thwart 1 million MIs & strokes

• by 2020, to ↑ CV health of the US population

to ↓ CVD deaths by 20%